Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Paliperidone ER Dose Distribution in Schizophrenia
NCT00473434Phase 3Completed
- Sponsor
- Janssen Pharmaceutical
- Start
- Apr 2007
- Primary completion
- Aug 2009
- Modality
- Small Molecules
01
Overview
A Phase 3 trial of paliperidone in schizophrenia, sponsored by Janssen Pharmaceutical. Started Apr 2007; status: completed.
02
Drugs
paliperidone
03
Conditions
schizophrenia
Beyond the preview
Go deeper on NCT00473434.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00473434.